Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned media
Abstract Background This study aimed to investigate the therapeutic potential of cell-free Dexamethasone (Dex) primed Wharton’s jelly Mesenchymal stem cells derived conditioned media (DW) in addressing complications associated with systemic lupus erythematosus (SLE), focusing on its immunomodulatory...
Saved in:
| Main Authors: | Khushbu Priya, Sonali Rawat, Doli Das, Manaswi Chaubey, Hiral Thacker, Kiran Giri, Shambhavi Singh, Madhukar Rai, Sujata Mohanty, Geeta Rai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Stem Cell Research & Therapy |
| Online Access: | https://doi.org/10.1186/s13287-025-04208-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metronidazole-induced cerebellar dysfunction: An underdiagnosed identity
by: Aditya Debuka, et al.
Published: (2025-07-01) -
Cutaneous vasculitis in SLE
by: Romy Kallas
Published: (2020-10-01) -
SLE: reconciling heterogeneity
by: Peter Izmirly, et al.
Published: (2019-12-01) -
Effect of seed maturity and priming on viability and vigour in tomato (Lycopersicon esculentum L.)
by: R. G. S. Rao, et al.
Published: (2005-01-01) -
Perineural dexamethasone: A concern!
by: Chitta R. Mohanty, et al.
Published: (2025-07-01)